{"id":"W4410417349","doi":"10.1136/bmjopen-2025-100159","title":"Efficacy and safety of novel complement inhibitors in atypical haemolytic uremic syndrome: a protocol for systematic review and meta-analysis","year":2025,"lang":"en","type":"article","venue":"BMJ Open","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Observational study; Intensive care medicine; Systematic review; Meta-analysis; Thrombotic microangiopathy; Cochrane Library; Protocol (science); MEDLINE; Evidence-based practice; Atypical hemolytic uremic syndrome; Publication bias; Orphan drug; Alternative medicine; Bioinformatics; Internal medicine; Pathology; Immunology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"systematic_review","genre":"protocol","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"protocol","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001567748,0.0001845092,0.002333493,0.0001846903,0.0000725315,0.00002430987,0.0003490172,0.00005983596,0.0002994298],"category_scores_gemma":[0.0003655296,0.0001318859,0.0002493677,0.0003543159,0.00008174402,0.00005345851,0.0005441104,0.00006522948,0.000003455308],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004106512,"about_ca_system_score_gemma":0.00008369782,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008645686,"about_ca_topic_score_gemma":0.0001278118,"domain_scores_codex":[0.9977486,0.0004112538,0.001259558,0.0003448695,0.00004905972,0.0001866634],"domain_scores_gemma":[0.9984829,0.0005415622,0.0003953394,0.0004916204,0.00006801709,0.00002059604],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.002611983,0.001514782,0.004681775,0.8178817,0.1537261,0.000006701526,0.0002165992,0.0000206496,0.001120855,0.005704858,0.01248437,0.0000296523],"study_design_scores_gemma":[0.04305691,0.000931813,0.03256149,0.124333,0.7928045,0.0001997856,0.0005142418,0.0001527799,0.0009615147,0.0003267756,0.002997464,0.001159766],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.001554312,0.003540216,0.0004207268,0.00122771,0.00001928409,0.9927602,0.0003450474,0.00001358519,0.0001188883],"genre_scores_gemma":[0.1799691,0.00000433933,0.0003033169,0.0003838783,0.000001355473,0.8186707,0.00008872064,0.000009165271,0.0005693629],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.6935487,"threshold_uncertainty_score":0.5378151,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1548612730056794,"score_gpt":0.456534877715915,"score_spread":0.3016736047102356,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}